The Biotech Forum

• 10/22/2024

  Unraveling the Enigma: Schrödinger, Inc.’s Complex Journey

• 10/19/2024

  Protagonist Therapeutics: Solid Outlook, But Is the Stock Worth It?

• 10/8/2024

  **CureVac’s Setback**

• 10/7/2024

  **Kiniksa Pharmaceuticals: A Growing Opportunity**

• 10/2/2024

  **Neurocrine Biosciences Play**

• 10/1/2024

  **4th Quarter Predictions**